SEC 13F Intelligence

Managers / Q3 2024 · view latest →

P2 Capital Partners, LLC

CIK 0001406313 · 590 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY, 10022 · (212) 508-5500

Reported Value
$876M
Q3 2024
Positions
15
Filings on Record
30
2019–present window
Filed
Nov 14, 2024
original filing

Summary

P2 Capital Partners, LLC reported $876M in U.S.-listed holdings across 15 positions for Q3 2024.

Its largest position, CBZ, represents 13.8% of the portfolio.

Compared with Q2 2024, the fund opened 0 new positions and exited 1.

Portfolio Metrics

Turnover
+14.8%
vs prior filed quarter
Top-10 Concentration
+88.8%
share of reported value
Largest Position
+13.8%
Cbiz

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $991MQ4 ’18Q1 ’19: $1.2BQ2 ’19: $1.3BQ3 ’19: $1.5BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $836MQ2 ’20: $1.2BQ3 ’20: $1.3BQ4 ’20: $1.5BQ4 ’20Q1 ’21: $1.5BQ2 ’21: $1.3BQ3 ’21: $1.2BQ4 ’21: $1.3BQ4 ’21Q1 ’22: $1.1BQ2 ’22: $883MQ3 ’22: $810MQ4 ’22: $756MQ4 ’22Q1 ’23: $780MQ2 ’23: $859MQ3 ’23: $764MQ4 ’23: $909MQ4 ’23Q1 ’24: $846MQ2 ’24: $912MQ3 ’24: $876MQ4 ’24: $589MQ4 ’24Q1 ’25: $515MQ2 ’25: $522MQ3 ’25: $520MQ4 ’25: $390MQ4 ’25Q1 ’26: $210Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 93.7%Other: 6.3%
  • Common Stock · 93.7% · $821M
  • Other · 6.3% · $55M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
R1 RCM INCSOLD OUT−10.80M0−$136M$0
SITESITEONE LANDSCAPE SUPPLY INCTRIMMED−140.5K30.6K−$16M$5M
CBZCBIZ INCADDED+696.5K1.80M+$39M$121M
IASINTEGRAL AD SCIENCE HLDNG COADDED+1.98M7.35M+$27M$80M
OPCHOPTION CARE HEALTH INCADDED+484.7K1.95M+$20M$61M
MIRMIRION TECHNOLOGIES INCTRIMMED−1.35M3.35M−$13M$37M
AVNTAVIENT CORPORATIONADDED+175.0K1.04M+$15M$53M
TN1TENNANT COADDED+76.0K727.4K+$6M$70M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2024

15 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CBZCBIZ INChistory →COM13.83%$121M1.80M
2BLKBBLACKBAUD INChistory →COM12.77%$112M1.32M
3ACHCACADIA HEALTHCARE COMPANY INhistory →COM11.37%$100M1.57M
4IASINTEGRAL AD SCIENCE HLDNG COhistory →COM9.08%$80M7.35M
5JBTJOHN BEAN TECHNOLOGIES CORPhistory →COM9.00%$79M800.2K
6TN1TENNANT COhistory →COM7.98%$70M727.4K
7OPCHOPTION CARE HEALTH INChistory →COM NEW6.95%$61M1.95M
8LIVANOVA PLCSHS6.30%$55M1.05M
9AVNTAVIENT CORPORATIONhistory →COM6.00%$53M1.04M
10FULFULLER H B COhistory →COM5.54%$49M611.3K
11MIRMIRION TECHNOLOGIES INChistory →COM CL A4.23%$37M3.35M
12ENSGENSIGN GROUP INChistory →COM3.78%$33M230.0K
13ENOVENOVIS CORPORATIONhistory →COM2.26%$20M460.0K
14SITESITEONE LANDSCAPE SUPPLY INCCOM0.53%$5M30.6K
15SHCSOTERA HEALTH COCOM0.38%$3M200.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$210M10May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$390M10Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$520M13Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$522M13Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$515M12May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$589M11Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$876M15Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$912M18Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$846M15May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$909M15Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$764M14Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$859M15Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$780M15May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$756M15Feb 23, 202313F-HRchanges · EDGAR ↗
Q3 2022$810M19Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$883M21Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.1B22May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.3B21Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.2B20Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.3B19Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.5B20May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.5B18Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B18Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.2B17Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$836M14May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.4B16Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.5B16Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.3B16Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.2B17May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$991M17Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.